Veraxa Biotech AG (NasdaqGM: VRXA)
Health Care · Biotechnology · DE
$1.11
-3.48% today · -89.4% 1Y
Veraxa Biotech AG (NasdaqGM: VRXA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $156.96M and employs 8 people.
Over the last twelve months the share price has lost 89.4%, trading between 0.95 and 27.36.
Tweenvest scores Veraxa Biotech AG across four factors: quality 34/100, value 63/100. Its strongest factor is value.
VRXA price history
Key figures
- Market cap
- $156.96M
- Revenue (TTM)
- $29.54K
- P/E
- -1.96
- EPS
- -5.80
- Dividend yield
- —
- Beta (5Y)
- 0.22
- 52-week high
- $27.36
- 52-week low
- $0.95
- Avg volume (3M)
- —
- Shares outstanding
- 141.41M
- Employees
- 8
- Next earnings
- —
About Veraxa Biotech AG
Veraxa Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody formats, and offers a proprietary technology platform for functional antibody screening and bioconjugation. Its product pipeline includes drug candidates such as ADCs and BITACs, with some in clinical development, and it provides partnership models for collaborative development from target identification to antibody and ADC creation. The company was founded in 2021 and is based in Heidelberg, Germany.
- ISIN
- CH1476899161
- Founded
- 2021
- Listed since
- Jun 9, 2026
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Invivyd, Inc.NasdaqGM: IVVD | $158.96M | $0.54 | -7.63% |
| Anbio BiotechnologyNasdaqGM: NNNN | $158.01M | $3.60 | -1.37% |
| Uwell Biopharma, Inc.TPEX: 7902 | $157.55M | NT$25.85 | +1.37% |
| Zentalis Pharmaceuticals, Inc.NasdaqGM: ZNTL | $157.23M | $1.60 | -5.88% |
| ImmuneOnco Biopharmaceuticals (Shanghai) Inc.SEHK: 1541 | $155.75M | HK$2.85 | -1.22% |
| Fate Therapeutics, Inc.NasdaqGM: FATE | $155.61M | $1.28 | -4.48% |
| ProQR Therapeutics N.V.NasdaqCM: PRQR | $155.46M | $1.10 | -4.35% |
| HLB Therapeutics Co.,Ltd.KOSDAQ: A115450 | $153.96M | ₩2,335.00 | -2.30% |